Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Mads Hald Andersen

Professor, dr.techn., Director

University Name

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

100%

Cell Biology

40%

Immunomodulation

60%

Regulatory T Cells

40%

Tumor Immunology

40%

Inflammatory Biology

30%

T Cell Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles22

The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling

Article Link

Year:

2025

A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies

Article Link

Year:

2025

Divergent Evolution of Malignant Subclones Maintains a Balance Between Induced Aggressiveness and Intrinsic Drug Resistance in T Cell Cancer.

Article Link

Year:

2025

Arginase-1-specific T cells target and modulate tumor-associated macrophages.

Article Link

Year:

2025

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Article Link

Year:

2025

Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome

Article Link

Year:

2024

The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets

Article Link

Year:

2024

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

Article Link

Year:

2024

TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts

Article Link

Year:

2024

Corrigendum: <i>Ex vivo</i> modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

Article Link

Year:

2024

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers.

Article Link

Year:

2024

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Article Link

Year:

2023

of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Article Link

Year:

2023

First in man study

Article Link

Year:

2023

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

Article Link

Year:

2023

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Article Link

Year:

2023

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Article Link

Year:

2023

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Article Link

Year:

2023

Novel immune modulatory vaccines targeting TGFβ

Article Link

Year:

2023

Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment

Article Link

Year:

2023

Tumor microenvironment antigens

Article Link

Year:

2023

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Article Link

Year:

2023

Collaborators19

morten gjerstorff

Professor

University of Southern Denmark

DENMARK

Lars Grøntved

University of Southern Denmark

DENMARK

Mikkel Bruhn Schuster

Københavns Universitet

DENMARK

Belinda Guo

University of Western Australia

AUSTRALIA

Simone Krebs

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Nikolaj Pagh Kristensen

University Hospital Erlangen

GERMANY

Luis Arnes

Københavns Universitet

DENMARK

Özcan Met

Københavns Universitet

DENMARK

Bo Porse

Københavns Universitet

DENMARK

Terkild Buus

Københavns Universitet

DENMARK

Morten Kranker Larsen

DENMARK

Matthew Linden

University of Western Australia

AUSTRALIA

Sine Reker Hadrup

Technical University of Denmark

DENMARK

Morten Andersen

Roskilde University

DENMARK

Sofia Bentivegna

University of Copenhagen

DENMARK

Marco Donia

Copenhagen University Hospital

DENMARK

Inge Marie Svane

Københavns Universitet

DENMARK

Lars Rønn Olsen

Technical University of Denmark

DENMARK

Per thor Straten

Københavns Universitet

DENMARK

How do I reach out?

Meet Kite AI